|  Help  |  About  |  Contact Us

Publication : CDK5 activator p35 downregulates E-cadherin precursor independently of CDK5.

First Author  Lin S Year  2008
Journal  FEBS Lett Volume  582
Issue  8 Pages  1197-202
PubMed ID  18325333 Mgi Jnum  J:201251
Mgi Id  MGI:5512836 Doi  10.1016/j.febslet.2008.02.053
Citation  Lin S, et al. (2008) CDK5 activator p35 downregulates E-cadherin precursor independently of CDK5. FEBS Lett 582(8):1197-202
abstractText  Dysfunction of E-cadherins often results in metastasis of cancerous cells. Here we show that p35, a critical regulator of cyclin-dependent kinase 5 (CDK5), specifically depletes the precursor form of E-cadherin, but not the mature form, by using a precursor-specific antibody. Most intriguingly, this downregulation of precursor E-cadherin by p35 is unequivocally independent of CDK5. Moreover, we found that p35 forms complexes with E-cadherin proteins. We also found that p35 co-expression can target E-cadherin to lysosomes and that p35-triggered disappearance of E-cadherin precursor can be blocked specifically by lysosomal protease inhibitors, indicating that p35 induces endocytosis and subsequent degradation of precursor E-cadherin.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Authors

3 Bio Entities

Trail: Publication

0 Expression